About Us


NanoMab Technology Limited is a privately held biopharmaceutical company focusing on the development of next generation radiopharmaceuticals for cancer precision medicine to be used in conjunction with the established network of SPECT/PET facilities all over the world. Our goal is to develop a pipeline of theranostic couple camelid antibodies with our proprietary camelid antibodies platform to address the unmet diagnostic and medical need for cancer patients in the world.